Recursion Pharmaceuticals Shares Are Trading Lower. The Company Announced Top-line Results of the SYCAMORE Trial for REC-994 in Symptomatic CCM Patients.
Recursion Pharmaceuticals Shares Are Trading Lower. The Company Announced Top-line Results of the SYCAMORE Trial for REC-994 in Symptomatic CCM Patients.
Recursion Pharmaceuticals股票交易下跌。該公司公佈了SYCAMORE試驗REC-994在症狀性CCm患者中的頂線結果。
Recursion Pharmaceuticals Shares Are Trading Lower. The Company Announced Top-line Results of the SYCAMORE Trial for REC-994 in Symptomatic CCM Patients.
Recursion Pharmaceuticals股票交易下跌。該公司公佈了SYCAMORE試驗REC-994在症狀性CCm患者中的頂線結果。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。